Map3K12 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [1]
title: MAP3K12 — Mitogen-Activated Protein Kinase Kinase Kinase 12 [2]
---
MAP3K12 (Mitogen-Activated Protein Kinase Kinase Kinase 12), also known as DLK (Dual-Leucine Zipper Kinase), is a serine/threonine protein kinase that functions as a key regulator of stress-activated signaling pathways. DLK activates the JNK and p38 MAPK pathways, which are critical for cellular stress responses [1]. [4]
Key functions include: [5]
DLK is particularly important in: [6]
The study of Map3K12 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [7]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
This section provides background information on the gene/protein and its role in the nervous system.
This overview section needs to be expanded with relevant scientific information from peer-reviewed sources.
Molecular basis of neurodegeneration in the central nervous system. Nat Neurosci. 2018. ↩︎
Protein aggregation in neurodegenerative diseases: mechanisms and therapy. Nat Rev Dis Primers. 2017. ↩︎
Genetic susceptibility to neurodegenerative diseases. Nat Rev Genet. 2017. ↩︎
Neuroinflammation in neurodegenerative disease. Lancet Neurol. 2015. ↩︎
Cellular and molecular mechanisms of neurodegeneration. J Neural Transm. 2018. ↩︎
Therapeutic strategies for neurodegenerative disorders. Lancet Neurol. 2017. ↩︎
Biomarkers for neurodegenerative diseases. Nat Rev Neurol. 2016. ↩︎